Stem is trading at $4.78, up +5.05%, with no confirmed near-term catalyst.

  • No new Stem announcement or fresh analyst action dated September 29 was found to explain the rise.
  • Stem’s September 25 UBS upgrade to Buy is recent background, but does not establish a direct catalyst for this move.
  • Broad market moves are modest and mixed, and do not clearly explain the gain.